Search

everythinglearnresearchcommunity

for

Search:↓

The document suggests that there might be an autoimmune link between polycystic ovary syndrome and Graves' disease.

CAH is a genetic disorder affecting cortisol production and causing hormonal imbalances, with treatment and diagnosis varying by form and symptoms.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Women with polycystic ovary syndrome have a higher risk of certain fractures.

Changing the diagnosis criteria for PCOS might miss women at risk for related health issues.

Obesity and negative body image harm mental health and quality of life in women with PCOS.

Cyperus rotundus rhizomes have medicinal properties useful for treating various health issues.

The study found a significant link between the renin-angiotensin system and insulin resistance in women with polycystic ovary syndrome.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The document explains that hirsutism, often caused by hormonal issues, can be managed with treatment to improve both physical appearance and mental health.

The document says PCOS is a common hormonal disorder in women, diagnosed by certain criteria, and managed with lifestyle changes and various medications.

Hormonal therapies, like flutamide and cyproterone acetate, are safe and effective for treating adult women's acne, especially those with hormone imbalance or resistant acne.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Differentiating PCOS from NCAH helps improve diagnosis and treatment.

Birth control pills containing cyproterone acetate improve the quality of life more for women with polycystic ovary syndrome after 6 months of use.

Balancing treatment effectiveness with side effects is crucial for relapsed follicular non-Hodgkin's lymphoma, especially in older patients.

Machine learning can accurately diagnose PCOS non-invasively using clinical and ultrasound features.

150 kHz electromagnetic radiation might help improve PCOS in rats.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

Women with PCOS have lower amylin levels, which are not related to their body weight.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

The document concludes that diagnosing PCOS requires a thorough approach, considering various symptoms and risks, and calls for improved methods to identify PCOS types and prevent diabetes.

Low-dose ethinyl estradiol and LNG-IUD are safer contraception options for obese women with PCOS.

PCOS may increase the risk of high blood pressure and heart issues.

Doctors should watch for and treat hormonal issues in obese patients beyond just diabetes.

Diagnosing Polycystic Ovary Syndrome is hard due to varying symptoms, no set criteria, and the need for better tests and education.